Technology Offerings

New Synthetic Compounds Boost Immunity Against Leishmaniasis, TB

The current treatments for tuberculosis and leishmaniosis have many drawbacks: long treatment duration,appearance of resistances,toxic side effects. Our new treatment suggests an immune activator based on a synthetic analogue of an active glycolipid.

Further information: PDF

TuTech Innovation GmbH (TuTech)
Phone: +49 40 76629-6541

Contact
Dr. Markus Kähler

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Comments (0)

Write a comment